Platelet-rich plasma: new clinical application: a pilot study for treatment of jumper's knee.
This study describes a simple, low-cost, minimally invasive way to apply PRP growth factors to chronic patellar tendinosis; 20 male athletes with a mean history of 20.7 months of pain received treatment, and outcomes were prospectively evaluated at 6 months follow-up. No severe adverse events were observed, and statistically significant improvements in all scores were recorded. The results suggest that this method may be safely used for the treatment of jumper's knee, by aiding the regeneration of tissue which otherwise has low healing potential.
Kon
Elizaveta
E
Biomechanics Laboratory, Department of Orthopaedic and Sports Trauma, Rizzoli Orthopaedic Institute, Via Di Barbiano 1/10, 40136 Bologna, Italy. e.kon@biomec.ior.it
Filardo
Giuseppe
G
Delcogliano
Marco
M
Presti
Mirco Lo
ML
Russo
Alessandro
A
Bondi
Alice
A
Di Martino
Alessandro
A
Cenacchi
Annarita
A
Fornasari
Pier Maria
PM
Marcacci
Maurilio
M
D000293:Adolescent; D000328:Adult; D001265:Athletic Injuries / Q000628:therapy*; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007267:Injections / Q000379:methods; D036341:Intercellular Signaling Peptides and Proteins / Q000008:administration & dosage*; D007718:Knee Injuries / Q000628:therapy; D008297:Male; D008875:Middle Aged; D017847:Patellar Ligament / Q000293:injuries; D010865:Pilot Projects; D015539:Platelet Activation; D053657:Platelet-Rich Plasma; D020127:Recovery of Function; D052256:Tendinopathy / Q000534:rehabilitation / Q000628:therapy*; D016896:Treatment Outcome; D014945:Wound Healing / Q000187:drug effects; D055815:Young Adult
D036341:Intercellular Signaling Peptides and Proteins